Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
FA Clinical Outcome Measures
NCT03090789 · View on ClinicalTrials.gov ↗
Study Summary
This multicenter natural history study aims to expand the network of clinical research centers in FA, and to provide a framework for facilitating therapeutic interventions. In addition, this study will lead to the development of valid yet sensitive clinical measures crucial to outcome assessment of patients with Friedreich's Ataxia. This study will support genetic modifier studies, biomarker studies, and frataxin protein level assessments by building a sample repository. This natural history study is no longer recruiting under this protocol NCT03090789 but remains actively recruiting under the harmonized study (UNIFAI) NCT06016946.
Conditions Studied
Study Locations (14)
Florida
- University of Florida - Neurology — Gainesville
- USF Ataxia Research Center — Tampa
Other
- All India Institute of Medical Sciences (Aiims) — New Delhi
- Auckland City Hospital — Auckland
California
- UCLA Ataxia Center — Los Angeles
Colorado
- University of Colorado — Denver
Georgia
- Emory University Hospital - Neurology — Atlanta
Iowa
- University of Iowa, Stead Family Children's Hospital — Iowa City
Ohio
- Ohio State University - Neurology — Columbus
Pennsylvania
- Children's Hospital of Philadelphia - Neurology — Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2001-01-01 |
| Est. Completion | 2030-01-01 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03090789
The ClinicalTrials.gov registry entry for NCT03090789 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Friedreich's Ataxia Research Alliance, which has 2 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Friedreich Ataxia appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT03090789 reports 14 study locations spanning 12 distinct geographic areas — top geographies include Florida, Other, California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT03090789 about?
NCT03090789 is a clinical study titled "FA Clinical Outcome Measures". This multicenter natural history study aims to expand the network of clinical research centers in FA, and to provide a framework for facilitating therapeutic interventions. In addition, this study will lead to the development of valid yet sensitive clinical measures crucial to outcome assessment of ...
What is the current status of trial NCT03090789?
This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2001-01-01. Estimated completion is 2030-01-01.
What conditions does trial NCT03090789 study?
This clinical trial studies the following conditions: Friedreich Ataxia, Neuro-Degenerative Disease. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT03090789?
This trial is sponsored by Friedreich's Ataxia Research Alliance, which has 2 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT03090789 being conducted?
This trial has 14 study locations across California, Colorado, Florida, Georgia, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.